{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:40:13Z","timestamp":1794948013842,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273451"],"award-info":[{"award-number":["82273451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203829"],"award-info":[{"award-number":["82203829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB842"],"award-info":[{"award-number":["2023AFB842"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A method for analyzing tumor evolution based on bulk RNA-sequencing data has not been reported yet. The epithelial\u2013mesenchymal transition (EMT) is an evolutionarily conserved cellular program with high heterogeneity and plasticity. In this study, we proposed an EMT heterogeneity-based molecular typing (EHBMT) method to visualize cancer evolution and guide personalized medicine. Multiplex immunohistochemical assay and single-cell analysis were performed to confirm the feasibility of this method. EHBMT divided gastric (cancer) tissues into an epithelial phenotype cluster (EPC), hybrid epithelial\u2013mesenchymal phenotype cluster (HPC) and mesenchymal phenotype cluster (MPC). Patients with gastric cancer with different EHBMT subtypes possessed distinct clinical features, molecular characteristics and prognostic outcomes. Furthermore, the proliferation ability of EPC, HPC and MPC subtypes decreases sequentially. Gene Ontology\/Kyoto Encyclopedia of Genes and Genomes analysis showed that HPC subtypes are associated with inflammation and immune activation. More importantly, EHBMT discovered a sharp increase in the proportion of the HPC subtype during gastric cancer evolution. Traceability analysis indicated that the surge in HPC in gastric cancer was due to the transition from approximately 70\u201380% of normal EPC cases to cancerous HPC\/MPC cases. In addition, the inflammatory factor IL-1\u03b2, highly expressed epithelial cells in the HPC subtype, should be a key driver for the decrease of epithelial cells by inducing EMT signaling. In conclusion, EHBMT is a novel method for visualizing cancer evolution using bulk transcriptomics. Gastric carcinogenesis is accompanied by a sharp increase in the proportion of HPC due to the abnormal EMT signaling pathway driven by an inflammatory microenvironment.<\/jats:p>","DOI":"10.1038\/s12276-025-01570-6","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:02:43Z","timestamp":1762128163000},"page":"2440-2457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["EHBMT, a method for visualizing tumor evolution, identifies a surge in gastric cancer with hybrid epithelial\u2013mesenchymal phenotypes due to an inflammatory microenvironment"],"prefix":"10.1038","volume":"57","author":[{"given":"Dandan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjian","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantian","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8527-5278","authenticated-orcid":false,"given":"Shanshan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"1570_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s12276-023-00969-3","volume":"55","author":"D Shin","year":"2023","unstructured":"Shin, D. & Cho, K. H. Critical transition and reversion of tumorigenesis. Exp. Mol. Med. 55, 692\u2013705 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1570_CR2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41419-025-08029-6","volume":"16","author":"D Li","year":"2025","unstructured":"Li, D. et al. Hypermethylation-mediated HNF4A silencing by Helicobacter pylori infection drives gastric cancer by disrupting epithelial cell polarity and activating EMT signaling. Cell Death Dis. 16, 688 (2025).","journal-title":"Cell Death Dis"},{"key":"1570_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/thno.60540","volume":"12","author":"X Li","year":"2022","unstructured":"Li, X. et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics 12, 620\u201338 (2022).","journal-title":"Theranostics"},{"key":"1570_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","volume":"70","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut 70, 464\u201375 (2021).","journal-title":"Gut"},{"key":"1570_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1164535","volume":"13","author":"M Proietto","year":"2023","unstructured":"Proietto, M. et al. Tumor heterogeneity: preclinical models, emerging technologies, and future applications. Front. Oncol. 13, 1164535 (2023).","journal-title":"Front. Oncol."},{"key":"1570_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41576-022-00553-x","volume":"24","author":"Z Seferbekova","year":"2023","unstructured":"Seferbekova, Z., Lomakin, A., Yates, L. R. & Gerstung, M. Spatial biology of cancer evolution. Nat. Rev. Genet. 24, 295\u2013313 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"1570_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1158\/1541-7786.MCR-19-1158","volume":"18","author":"KJ Pienta","year":"2020","unstructured":"Pienta, K. J., Hammarlund, E. U., Axelrod, R., Amend, S. R. & Brown, J. S. Convergent evolution, evolving evolvability, and the origins of lethal cancer. Mol. Cancer Res. 18, 801\u201310 (2020).","journal-title":"Mol. Cancer Res."},{"key":"1570_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","volume":"27","author":"N McGranahan","year":"2015","unstructured":"McGranahan, N. & Swanton, C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27, 15\u201326 (2015).","journal-title":"Cancer Cell"},{"key":"1570_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs, A. M. et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat. Cell Biol. 19, 518 (2017).","journal-title":"Nat. Cell Biol."},{"key":"1570_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"CL Chaffer","year":"2016","unstructured":"Chaffer, C. L., Juan, B. P., Lim, E. & Weinberg, R. A. EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 35, 645\u201354 (2016).","journal-title":"Cancer Metastasis Rev."},{"key":"1570_CR11","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.celrep.2016.02.034","volume":"14","author":"E Beerling","year":"2016","unstructured":"Beerling, E. et al. Plasticity between epithelial and mesenchymal states unlinks EMT from metastasis-enhancing stem cell capacity. Cell Rep. 14, 2281\u20138 (2016).","journal-title":"Cell Rep."},{"key":"1570_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tcb.2015.07.012","volume":"25","author":"X Ye","year":"2015","unstructured":"Ye, X. & Weinberg, R. A. Epithelial\u2013mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 25, 675\u201386 (2015).","journal-title":"Trends Cell Biol."},{"key":"1570_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41576-020-0265-5","volume":"22","author":"AS Nam","year":"2021","unstructured":"Nam, A. S., Chaligne, R. & Landau, D. A. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics. Nat. Rev. Genet. 22, 3\u201318 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"1570_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29, 212\u201326 (2019).","journal-title":"Trends Cell Biol."},{"key":"1570_CR15","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","volume":"171","author":"SV Puram","year":"2017","unstructured":"Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611 (2017).","journal-title":"Cell"},{"key":"1570_CR16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/bjc.2011.405","volume":"105","author":"A Lecharpentier","year":"2011","unstructured":"Lecharpentier, A. et al. Detection of circulating tumour cells with a hybrid (epithelial\/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br. J. Cancer 105, 1338\u201341 (2011).","journal-title":"Br. J. Cancer"},{"key":"1570_CR17","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-14-2535","volume":"75","author":"MJ Schliekelman","year":"2015","unstructured":"Schliekelman, M. J. et al. Molecular portraits of epithelial, mesenchymal, and hybrid states in lung adenocarcinoma and their relevance to survival. Cancer Res. 75, 1789\u2013800 (2015).","journal-title":"Cancer Res."},{"key":"1570_CR18","doi-asserted-by":"publisher","first-page":"e13423","DOI":"10.1111\/cpr.13423","volume":"56","author":"D Li","year":"2023","unstructured":"Li, D. et al. Heterogeneity and plasticity of epithelial\u2013mesenchymal transition (EMT) in cancer metastasis: Focusing on partialEMT and regulatory mechanisms. Cell Prolif. 56, e13423 (2023).","journal-title":"Cell Prolif"},{"key":"1570_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu, R. et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat. Med. 21, 449\u201356 (2015).","journal-title":"Nat. Med."},{"key":"1570_CR20","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","volume":"39","author":"KP Simeonov","year":"2021","unstructured":"Simeonov, K. P. et al. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer Cell 39, 1150\u201362 (2021).","journal-title":"Cancer Cell"},{"key":"1570_CR21","doi-asserted-by":"crossref","unstructured":"da Silva-Diz, V. et al. Cancer cell plasticity: impact on tumor progression and therapy response. Semin. Cancer Biol. 53, 48\u201358 (2018).","DOI":"10.1016\/j.semcancer.2018.08.009"},{"key":"1570_CR22","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.trecan.2022.01.014","volume":"8","author":"DP Cook","year":"2022","unstructured":"Cook, D. P. & Wrana, J. L. A specialist-generalist framework for epithelial-mesenchymal plasticity in cancer. Trends Cancer 8, 356\u201368 (2022).","journal-title":"Trends Cancer"},{"key":"1570_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111836","volume":"131","author":"D Li","year":"2024","unstructured":"Li, D., Huang, P., Xia, L., Leng, W. & Qin, S. Cancer-associated fibroblasts promote gastric cancer cell proliferation by paracrine FGF2-driven ribosome biogenesis. Int. Immunopharmacol. 131, 111836 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"1570_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2024.108193","volume":"250","author":"D Li","year":"2024","unstructured":"Li, D. et al. A new high-throughput screening methodology for the discovery of cancer-testis antigen using multi-omics data. Comput. Methods Prog. Biomed. 250, 108193 (2024).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"1570_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.806324","volume":"12","author":"S Lou","year":"2021","unstructured":"Lou, S. et al. Patient-level DNA damage repair pathway profiles and anti-tumor immunity for gastric cancer. Front. Immunol. 12, 806324 (2021).","journal-title":"Front. Immunol."},{"key":"1570_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccell.2018.12.003","volume":"35","author":"DG Mun","year":"2019","unstructured":"Mun, D. G. et al. Proteogenomic characterization of human early-onset gastric cancer. Cancer cell 35, 111\u201324.e10 (2019).","journal-title":"Cancer cell"},{"key":"1570_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar, V. et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 12, 670\u201391 (2022).","journal-title":"Cancer Discov."},{"key":"1570_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41419-024-06744-0","volume":"15","author":"S Qin","year":"2024","unstructured":"Qin, S. et al. A novel TGF\u03b2\/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression. Cell Death Dis. 15, 368 (2024).","journal-title":"Cell Death Dis."},{"key":"1570_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/emmm.200900043","volume":"1","author":"JM L\u00f3pez-Novoa","year":"2009","unstructured":"L\u00f3pez-Novoa, J. M. & Nieto, M. A. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol. Med. 1, 303\u201314 (2009).","journal-title":"EMBO Mol. Med."},{"key":"1570_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12029-021-00801-z","volume":"54","author":"B Sengez","year":"2023","unstructured":"Sengez, B., Carr, B. I. & Alotaibi, H. EMT and inflammation: crossroads in HCC. J. Gastrointest. Cancer 54, 204\u201312 (2023).","journal-title":"J. Gastrointest. Cancer"},{"key":"1570_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","volume":"11","author":"M Suarez-Carmona","year":"2017","unstructured":"Suarez-Carmona, M., Lesage, J., Cataldo, D. & Gilles, C. EMT and inflammation: inseparable actors of cancer progression. Mol. Oncol. 11, 805\u201323 (2017).","journal-title":"Mol. Oncol."},{"key":"1570_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1158\/2159-8290.CD-23-0530","volume":"14","author":"G Ciriello","year":"2024","unstructured":"Ciriello, G. et al. Cancer evolution: a multifaceted affair. Cancer Discov. 14, 36\u201348 (2024).","journal-title":"Cancer Discov."},{"key":"1570_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/eva.13190","volume":"14","author":"AM Dujon","year":"2021","unstructured":"Dujon, A. M. et al. Identifying key questions in the ecology and evolution of cancer. Evol. Appl. 14, 877\u201392 (2021).","journal-title":"Evol. Appl."},{"key":"1570_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41576-020-0223-2","volume":"21","author":"DE Wagner","year":"2020","unstructured":"Wagner, D. E. & Klein, A. M. Lineage tracing meets single-cell omics: opportunities and challenges. Nat. Rev. Genet. 21, 410\u201327 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"1570_CR35","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41568-024-00734-2","volume":"24","author":"L Laplane","year":"2024","unstructured":"Laplane, L. & Maley, C. C. The evolutionary theory of cancer: challenges and potential solutions. Nat. Rev. Cancer 24, 718\u201333 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"1570_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C. & Lordick, F. Gastric cancer. Lancet 396, 635\u201348 (2020).","journal-title":"Lancet"},{"key":"1570_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-021-00412-7","volume":"22","author":"KG Yeoh","year":"2022","unstructured":"Yeoh, K. G. & Tan, P. Mapping the genomic diaspora of gastric cancer. Nat. Rev. Cancer 22, 71\u201384 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1570_CR38","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/j.gastro.2023.01.018","volume":"164","author":"RJ Huang","year":"2023","unstructured":"Huang, R. J., Laszkowska, M., In, H., Hwang, J. H. & Epplein, M. Controlling gastric cancer in a world of heterogeneous risk. Gastroenterology 164, 736\u201351 (2023).","journal-title":"Gastroenterology"},{"key":"1570_CR39","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.3748\/wjg.v21.i37.10510","volume":"21","author":"P Hudler","year":"2015","unstructured":"Hudler, P. Challenges of deciphering gastric cancer heterogeneity. World J. Gastroenterol. 21, 10510\u201327 (2015).","journal-title":"World J. Gastroenterol."},{"key":"1570_CR40","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3748\/wjg.v24.i24.2567","volume":"24","author":"JP Gao","year":"2018","unstructured":"Gao, J. P., Xu, W., Liu, W. T., Yan, M. & Zhu, Z. G. Tumor heterogeneity of gastric cancer: from the perspective of tumor-initiating cell. World J. Gastroenterol. 24, 2567\u201381 (2018).","journal-title":"World J. Gastroenterol."},{"key":"1570_CR41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/hel.12254","volume":"20","author":"C Figueiredo","year":"2015","unstructured":"Figueiredo, C., Costa, S., Karameris, A. & Machado, J. C. Pathogenesis of gastric cancer. Helicobacter 20, 30\u20135 (2015).","journal-title":"Helicobacter"},{"key":"1570_CR42","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1111\/cas.14191","volume":"110","author":"SWT Ho","year":"2019","unstructured":"Ho, S. W. T. & Tan, P. Dissection of gastric cancer heterogeneity for precision oncology. Cancer Sci. 110, 3405\u201314 (2019).","journal-title":"Cancer Sci."},{"key":"1570_CR43","doi-asserted-by":"crossref","unstructured":"Youssef, K. K. et al. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations. Nat. Cancer 5, 1660\u20131680 (2024).","DOI":"10.1038\/s43018-024-00839-5"},{"key":"1570_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1770-1","volume":"17","author":"V Masola","year":"2019","unstructured":"Masola, V. et al. In vitro effects of interleukin (IL)-1\u03b2 inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. J. Transl. Med. 17, 12 (2019).","journal-title":"J. Transl. Med."},{"key":"1570_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57285-y","volume":"10","author":"R Li","year":"2020","unstructured":"Li, R. et al. Chronic IL-1\u03b2-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Sci. Rep. 10, 377 (2020).","journal-title":"Sci. Rep."},{"key":"1570_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.canlet.2014.08.015","volume":"354","author":"EA Perez-Yepez","year":"2014","unstructured":"Perez-Yepez, E. A., Ayala-Sumuano, J. T., Lezama, R. & Meza, I. A novel \u03b2-catenin signaling pathway activated by IL-1\u03b2 leads to the onset of epithelial\u2013mesenchymal transition in breast cancer cells. Cancer Lett. 354, 164\u201371 (2014).","journal-title":"Cancer Lett."},{"key":"1570_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-10-100","volume":"10","author":"AM Doerner","year":"2009","unstructured":"Doerner, A. M. & Zuraw, B. L. TGF-\u03b21 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1\u03b2 but not abrogated by corticosteroids. Respir. Res. 10, 100 (2009).","journal-title":"Respir. Res."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01570-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01570-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01570-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:02:36Z","timestamp":1765296156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01570-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["1570"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01570-6","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Acknowledgement section has been updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study is approved by the Ethics Committee of Hubei University of Medicine (2024-TH-021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}